image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 4.58
4.33 %
$ 6.81 M
Market Cap
-0.45
P/E
BALANCE SHEET
7.07 M ASSETS
-40.36%
9.65 M LIABILITIES
24.22%
-2.58 M EQUITY
-63.15%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Evoke Pharma, Inc.
image
Current Assets 6.83 M
Cash & Short-Term Investments 4.74 M
Receivables 673 K
Other Current Assets 1.41 M
Non-Current Assets 242 K
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 242 K
Current Liabilities 3.04 M
Accounts Payable 1.71 M
Short-Term Debt 5 M
Other Current Liabilities -3.68 M
Non-Current Liabilities 6.61 M
Long-Term Debt 5 M
Other Non-Current Liabilities 1.61 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 4.7 9.8 9.1 8.1 5.7 5.3 7.7 9.0 8.7 14.2 24.2 0.1 0.9
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0.7 0.6 0.3 23.3 K 0 0 0 0 0 0 0 0 0
Inventory 0.5 0.3 0.2 0.2 0 0 0 0 0 0 0 0 0
Other Current Assets 0.9 1.0 0.9 1.0 0.6 0.3 0.3 0.3 0.8 1.1 0.2 0 39.5 K
Total Current Assets 6.8 11.7 10.6 9.3 6.2 5.6 7.9 9.3 9.5 15.2 24.4 0.1 0.9
PP&E 0 0.1 12.4 K 0.1 0.1 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.2 (0.1) 12.4 K 11.6 K 11.6 K 11.6 K 11.6 K 11.6 K 8 K 53 K 0.6 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 7.1 11.9 10.6 9.4 6.4 5.7 7.9 9.3 9.5 15.3 25.0 0.1 0.9
LIABILITIES
Accounts Payable 1.7 0.9 0.9 1.3 1.0 0.5 1.0 0.5 0.9 1.0 0.3 96.8 K 0
Short Term Debt 5.0 0.3 24.9 K 0.2 0.3 0 0 0 0.1 0.2 1.4 0 0
Other Current Liabilities (3.7) 0.5 0.5 6.0 0.7 1.2 1.0 0.9 0.8 0.7 0.6 0.5 0.3
Total Current Liabilities 3.0 1.7 1.4 7.5 2.0 1.6 2.1 1.4 1.8 1.9 2.3 0.6 0.3
Long Term Debt 5.0 5.0 5.0 5.0 0 0 0 0 4.2 4.2 1.5 1.0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 1.6 1.1 0.6 0.1 0 0 3.7 4.1 0 0 6.83 K 18.2 0
Total Liabilities 9.6 7.8 7.0 12.6 2.0 1.6 5.8 5.5 6.1 6.1 3.8 19.8 18.6
EQUITY
Common Stock 334 334 3.27 K 2.66 K 2.44 K 1.74 K 1.54 K 1.24 K 720 611 610 124 124
Retained Earnings (123.4) (115.6) (107.4) (98.9) (85.7) (78.6) (71.0) (58.8) (48.1) (35.9) (22.7) (19.9) (17.8)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0 0 0 0 (25.0) (18.2) 0
Total Equity (2.6) 4.1 3.6 (3.2) 4.4 4.0 2.2 3.8 3.5 9.2 21.2 (19.7) (17.7)
Total Liabilities and Equity 7.1 11.9 10.6 9.4 6.4 5.7 7.9 9.3 9.5 15.3 25.0 0.1 0.9
SHARES OUTSTANDING
Common Shares Outstanding 0.3 0.3 0.2 0.2 0.2 0.1 0.1 64.8 K 45 K 41.9 K 16.4 K 8.61 K 0.2